-
1
Quantification of Antiretroviral Drug Emtricitabine in Human Plasma by Surface Enhanced Raman Spectroscopy
Published 2024-11-01Get full text
Article -
2
Utilization Patterns and Projected Demand of Antiretroviral Drugs in Low- and Middle-Income Countries
Published 2011-01-01Get full text
Article -
3
Assessing HIV/AIDS patients’ access to antiretroviral drugs using the healthcare accessibility framework: a cross-sectional study from Shandong, China
Published 2025-02-01Subjects: “…Antiretroviral drugs…”
Get full text
Article -
4
-
5
Clinical testing of antiretroviral drugs as future prevention against vaginal and rectal transmission of HIV infection – a review of currently available results
Published 2019-09-01“…This review summarizes the results obtained during long-term clinical testing (2005–2018) of antiretroviral drugs against vaginal and rectal transmission of HIV infection.…”
Get full text
Article -
6
Performance of antiretroviral drugs supply chain management and related challenges in Amhara National Regional State, Ethiopia....
Published 2025-03-01“…However, interruptions in access and stock outs are the major challenges in the supply chain of antiretroviral drugs. The issues are very high, particularly in developing countries like Ethiopia. …”
Get full text
Article -
7
Exploring Zinc C295 as a Dual HIV-1 Integrase Inhibitor: From Strand Transfer to 3′-Processing Suppression
Published 2024-12-01Subjects: Get full text
Article -
8
Drugs as a cause of perforating dermatoses – a literature review
Published 2024-11-01“…Perforating dermatoses can be induced by the molecularly targeted therapy drugs (sorafenib, nilotinib, dasatinib, erlotinib, gefitinib, vemurafenib, lenvatinib, sirolimus, bevacizumab, necitumumab, panitumumab, cetuximab, bendamustine-rituximab, terepril), monoclonal antibodies (infliximab, etanercept, ranibizumab, natalizumab), as well as immunomodulatory imide drugs (lenalidomide, leflunomide), antiretroviral drugs (indinavir, telaprevir) and penicillamine. …”
Get full text
Article -
9
Kaposi´s sarcoma, epidemic type. Case presentation
Published 2009-05-01“…It affects approximately 20% of people with HIV that don’t take antiretroviral drugs. It is more common in homosexual’s patients, but may appear in any HIV positive individual, in Africa where heterosexual HIV transmission route is the most important can also be found in children and women. …”
Get full text
Article -
10
Antiretroviral therapies and status of people living with HIV in Japan: An update from hospital survey and national database.
Published 2025-01-01“…A significant transition to single-tablet regimens and newer, highly effective antiretroviral drugs was observed, optimizing treatment adherence and outcomes. …”
Get full text
Article -
11
Hybrid optimal control for HIV multi-drug therapies: A finite set control transcription approach
Published 2012-09-01“…In this study, the treatment of Human Immunodeficiency Virus (HIV) infection is investigated through an optimal structured treatment interruption (STI) schedule of two classes of antiretroviral drugs, mainly, reverse transcriptase inhibitors and protease inhibitors. …”
Get full text
Article -
12
Assessment of Antiretroviral Treatment Adherence among Children Attending Care at a Tertiary Hospital in Southeastern Nigeria
Published 2017-01-01“…Our aim was to assess the antiretroviral drugs adherence status of HIV-infected children attending care at a tertiary hospital in Southeastern Nigeria. …”
Get full text
Article -
13
Accessibility to, Acceptability of, and Adherence to HIV/AIDS Prevention Services by Men Who Have Sex with Men: Challenges Encountered at Facility Level
Published 2016-01-01“…Over 70% of MSM reported that TB drugs, antiretroviral drugs, lubricants, condoms, and other STI treatment services were accessible. …”
Get full text
Article -
14
Characterization of the Protective HIV-1 CTL Epitopes and the Corresponding HLA Class I Alleles: A Step towards Designing CTL Based HIV-1 Vaccine
Published 2014-01-01“…Human immunodeficiency virus (HIV) possesses a major threat to the human life largely due to the unavailability of an efficacious vaccine and poor access to the antiretroviral drugs against this deadly virus. High mutation rate in the viral genome underlying the antigenic variability of the viral proteome is the major hindrance as far as the antibody based vaccine development is concerned. …”
Get full text
Article -
15
Challenges in Providing Treatment and Care for Viral Hepatitis among Individuals Co-Infected with HIV in Resource-Limited Settings
Published 2012-01-01“…The options for antiretroviral drugs are limited and rely on global funds and research facilities. …”
Get full text
Article -
16
The Palatability of Lopinavir and Ritonavir Delivered by an Innovative Freeze-Dried Fast-Dissolving Tablet Formulation
Published 2018-01-01“…Negative hedonic sensory qualities of HIV antiretroviral drugs often reduce patient adherence particularly in pediatric populations requiring oral consumption. …”
Get full text
Article -
17
Modelling the immunopathogenesis of HIV-1 infection and the effect of multidrug therapy: The role of fusion inhibitors in HAART
Published 2008-05-01“…In this study, we develop a new mathematical model ofthe immuno-pathogenesis of HIV-1 infection, which we use to assess virologicalresponses to both intracellular and extracellular antiretroviral drugs. We firstdevelop a basic mathematical model of the immuno-pathogenesis of HIV-1infection that incorporates three distinct stages in the infection cycle of HIV-1:entry of HIV-1 into the cytoplasm of CD4+ T cells, transcription of HIV-1RNA to DNA within CD4+ T cells, and production of HIV-1 viral particleswithin CD4+ T cells. …”
Get full text
Article -
18
Efficacy and safety of an Albuvirtide-based regimen for preventing mother-to-child transmission of multidrug-resistant HIV: a case report
Published 2025-01-01“…Abstract Background Antiretroviral drugs are essential for preventing mother-to-child transmission (MTCT) of HIV in HIV-infected pregnant women. …”
Get full text
Article -
19
Prevalence and factors associated with xerostomia in patients hospitalized due AIDS-related complications
Published 2024-10-01“…This fact may be associated with low salivary flow and the use of various drugs, including antiretroviral drugs.…”
Get full text
Article -
20
Impaired Urine Dilution Capability in HIV Stable Patients
Published 2014-01-01“…Viral infection itself and the use of some antiretroviral drugs contribute to this condition. The thick ascending limb of Henle’s loop (TALH) is the tubule segment where free water clearance is generated, determining along with glomerular filtration rate the kidney’s ability to dilute urine. …”
Get full text
Article